Operating cash flow decreased 179.4%
Operating cash flow changed -179.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$1.0M→-$2.9M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →LASE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 148.1%
Operating income changed -148.1% from the comparable as-filed period.
-$962,688→-$2.4M3 prior comparisons
Gross margin moved 4505 bp lower
Gross margin changed -4505 basis points from the comparable as-filed period.
53.49%→8.44%3 prior comparisons
Net income decreased 84.8%
Net income changed -84.8% from the comparable as-filed period.
-$1.8M→-$3.3M3 prior comparisons
Operating margin moved 9518 bp lower
Operating margin changed -9518 basis points from the comparable as-filed period.
-37.04%→-132.22%3 prior comparisons
Revenue decreased 30.5%
Revenue changed -30.5% from the comparable as-filed period.
$2.6M→$1.8M3 prior comparisons
Gross profit decreased 89.0%
Gross profit changed -89.0% from the comparable as-filed period.
$1.4M→$152,4733 prior comparisons
Research & development increased 66.8%
Research & development changed +66.8% from the comparable as-filed period.
$131,287→$219,0063 prior comparisons
Total assets decreased 29.2%
Total assets changed -29.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$14.9M→$10.6M4 prior comparisons
Current assets increased 37.5%
Current assets changed +37.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.3M→$4.6M4 prior comparisons
Shares outstanding increased 251.5%
Shares outstanding changed +251.5% from the comparable as-filed period.
14,276,150→50,177,7161 prior comparisons
Trade receivables decreased 42.1%
Trade receivables changed -42.1% from the comparable as-filed period.
$877,522→$508,1091 prior comparisons
Inventory / revenue moved 846 bp higher
Inventory / revenue changed +846 basis points from the comparable as-filed period.
56.82%→65.28%3 prior comparisons
Current liabilities increased 21.6%
Current liabilities changed +21.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$6.3M→$7.7M4 prior comparisons
Inventory decreased 20.1%
Inventory changed -20.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.5M→$1.2M4 prior comparisons
Working capital / assets moved 932 bp lower
Working capital / assets changed -932 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-20.05%→-29.38%4 prior comparisons
Operating cash-flow margin moved 12031 bp lower
Operating cash-flow margin changed -12031 basis points from the comparable as-filed period.
-39.84%→-160.15%3 prior comparisons
R&D / revenue moved 707 bp higher
R&D / revenue changed +707 basis points from the comparable as-filed period.
5.05%→12.12%3 prior comparisons
Receivables / revenue moved 563 bp lower
Receivables / revenue changed -563 basis points from the comparable as-filed period.
33.76%→28.13%1 prior comparisons
Stockholders' equity changed across a sign change
Stockholders' equity changed -121.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$4.3M→-$911,5532 prior comparisons
Current ratio increased 13.1%
Current ratio changed +13.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
0.53→0.64 prior comparisons
Working capital decreased 3.7%
Working capital changed -3.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$3.0M→-$3.1M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.